Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Cancer Science|March 21, 2009
The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1Junko H Ohyashiki, Chiaki Kobayashi, Ryoko Hamamura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 17, 2009
Effective and well tolerated treatment with melphalan and dexamethasone for primary systemic AL amyloidosis with cardiac involvementSeiichiro YOSHIZAWA, Daigo AKAHANE, Hiroaki FUJIMOTO, et al.
Japanese Journal of Clinical Oncology|April 5, 2002
De novo appearance of t(7;13)(q10;q33) in the leukemic phase of myelodysplastic syndrome: a case reportTomotaka Iguchi, Goro Sashida, Ken Kawakubo, et al.
International Journal of Hematology|January 5, 2010
Successful prior treatment with dasatinib followed by stem cell transplantation in a patient with CML in blastic crisis with a BCR-ABL mutationMoritaka Gotoh, Tetsuzo Tauchi, Seiichiro Yoshizawa, et al.
Leukemia & Lymphoma|April 15, 2003
Natural killer cell lymphoma in the duodenumMasahiko Sumi, Tetsuzo Tauchi, Goro Sashida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 5, 2002
[Chronic myeloid leukemia associated with sustained severe pancytopenia after imatinib mesylate therapy]Masahiko Sumi, Tetsuzo Tauchi, Takashi Shimamoto, et al.
Cancer Biology & Therapy|October 9, 2013
Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with nilotinib against BCR-ABL-positive leukemia cells involves the ABL kinase domain mutationSeiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, et al.
Plos One|March 4, 2014
Combining the ABL1 kinase inhibitor ponatinib and the histone deacetylase inhibitor vorinostat: a potential treatment for BCR-ABL-positive leukemiaSeiichi Okabe, Tetsuzo Tauchi, Shinya Kimura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphasesGoro Sashida, Junko H Ohyashiki, Akihiro Nakajima, et al.
International Journal of Oncology|October 9, 2002
Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cellsMasafumi Misawa, Tetsuzo Tauchi, Goro Sashida, et al.
Pageof 8